|
Providing and Receiving Effective Feedback |
02/02/2024 - 12:15pm to 1:00pm CST |
|
New Paradigms for the Treatment of Type 1 Diabetes |
02/16/2024 - 12:15pm to 1:00pm CST |
|
The Mouse Metabolism and Phenotyping Core at Baylor College of Medicine |
03/01/2024 - 12:15pm to 1:00pm CST |
|
Bad to the Bone: Systemic Consequences of Pathologic Bone Destruction |
03/15/2024 - 12:15pm to 1:00pm CDT |
|
Genetic and Epigenomic Mechanisms for Circadian Biology and Medicine |
03/29/2024 - 12:15pm to 1:00pm CDT |
|
The Importance of Body Fat Distribution: An Emerging Role for Fat Fibrosis |
04/05/2024 - 12:15pm to 1:00pm CDT |
|
Metabolic Dysfunction Associated Steatotic Liver Disease: Making Sense of a New Name, New Guidelines, and New Medication |
04/19/2024 - 12:15pm to 1:00pm CDT |
|
Role of Multidisciplinary Clinics in the Management of Thyroid Cancer |
05/03/2024 - 12:15pm to 1:00pm CDT |
|
Evaluating Current Practices of Insulin Orders in Diabetes Patients Admitted to the Vascular Surgery Team at MEDVAMC/Clinical Outcomes of Thyroid Cancer Patients Enrolled in a Comprehensive Thyroid Cancer Survivorship Program |
05/17/2024 - 12:15pm to 1:15pm CDT |
|
Implementing New Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Screening Guidelines in Pts/Phenotypic Analysis in Pheochromocytomas and Paragangliomas/The Effects of Aromatase Inhibitors on COVID-19 outcomes in US Veterans |
05/31/2024 - 12:15pm to 1:15pm CDT |